Medical College of Wisconsin
CTSIResearch InformaticsREDCap

CURRICULUM VITAE

Robert L. Truitt PhD
Emeritus Professor
Department of Pediatrics
Division of Pediatrics Hematology Oncology Blood and Marrow Transplant

OFFICE ADDRESS:
8701 Watertown Plank Road
Milwaukee, WI 53226

EDUCATION:
1964 - 06/1968 BA - Microbiology, Southern Illinois University, Carbondale, IL
1968 - 06/1973 PhD - Microbiology, Southern Illinois University, Carbondale, IL

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1972 - 1974 Postdoctoral Fellow, Lobund Laboratory, University of Notre Dame, Notre Dame, IN
1974 - 1975 Postdoctoral Fellow, Winter Research Laboratory, Mount Sinai Medical Center, Milwaukee, WI

FACULTY APPOINTMENTS:
1975 - 1977 Research Associate, Winter Research Laboratory, Mount Sinai Medical Center, Milwaukee, WI
1977 - 1983 Senior Scientist, Winter Research Laboratory, Mount Sinai Medical Center, Milwaukee, WI
1983 - 1984 Associate Scientist, Department of Medicine, Milwaukee Clinical Campus, University of Wisconsin Medical School, Milwaukee, WI
1983 - 1984 Associate Director, Winter Research Laboratory, Mount Sinai Medical Center, Milwaukee, WI
1984 - 1988 Research Associate Professor, Dept. of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
1988 - 1991 Research Professor, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
1991 - 2010 Professor of Immunology with Tenure, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
1997 - 2010 Professor, Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, WI
2002 - 2009 Senior Investigator, Blood Research Institute, Blood Center of Southeastern Wisconsin, Milwaukee, WI
2010 - Present Emeritus Professor of Pediatrics, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
1985 - 1990 Director, Immunology/Transplantation Program, Cancer Center, Medical College of Wisconsin, Milwaukee, WI
1985 - Present Full Member, Cancer Center, Medical College of Wisconsin, Milwaukee, WI
1985 - 1998 Doctorate Staff, Hematology Section, Children's Hospital of Wisconsin, Milwaukee, WI
1988 - 2001 Coordinator, FACScan Flow Cytometry Shared Facility, Cancer Center, Medical College of Wisconsin, Milwaukee, WI
1992 - 1995 Research Coordinator, Biological Response Modifiers Program, Cancer Center, Medical College of Wisconsin, Milwaukee, WI
1998 - 2001 Co-Leader, Bone Marrow Transplantation Program, Cancer Center, Medical College of Wisconsin, Milwaukee, WI
1998 - 1999 Associate Director for Planning, Cancer Center, Medical College of Wisconsin, Milwaukee, WI
2001 - 2008 Program Director, Experimental BMT and Immunotherapy Program, Cancer Center, Medical College of Wisconsin, Milwaukee, WI
2002 - 2007 Associate Director, Basic Science Research, Cancer Center, Medical College of Wisconsin, Milwaukee, WI
2008 - 2009 Program Co-Director, Blood & Marrow Transplant Program, Cancer Center, Medical College of Wisconsin, Milwaukee, WI
2008 - 2009 Associate Director of Research, Cancer Center, Medical College of Wisconsin, Milwaukee, WI
2010 - Present Associate Director of Research Resources, Cancer Center, Medical College of Wisconsin, Milwaukee, WI

AWARDS AND HONORS:
1972 - 1973 Postdoctoral Fellowship, United Cancer Council
1973 - 1975 Damon Runyon Memorial Fund , Cancer Research Postdoctoral Fellowship
1976 - 1978 Special Fellow Award, Leukemia Society of America
1978 - 1983 Scholar Award, Leukemia Society of America
2007 Distinguished Service Award, Medical College of Wisconsin
2009 Health Care Heroes Award, BizTimes-Milwaukee for advancements in health care in pediatric oncology

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1972 American Society for Microbiology (Member)
1974 Association for Gnotobiotics (Member )
1975 International Society of Experimental Hematology (Member )
1976 American Association of Immunologists (Member )
1980 American Association for the Advancement of Science (Member )
1980 - 1981 Association for Gnotobiotics (Vice-President )
1980 - 1983 Association for Gnotobiotics (Board of Directors )
1981 - 1982 Association for Gnotobiotics (President )
1984 International Association for Gnotobiotics (Member )
1985 Pediatric Oncology Group/Children’s Oncology Group (Member)
1991 - 1993 Association for Gnotobiotics (Board of Directors )
2001 American Society of Hematology (Member )
2001 Great Lakes International Imaging and Flow Cytometry Association (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
1989 T-cell depletion in allogeneic bone marrow transplantation: Progress and problems. Haematologica 74:235-248
2003 Targeting DCs to Induce Regulatory T-cells In Vivo. Commentary - Inside Blood, Blood, 101: 4649-4650
Editorial Board
1995 - Present Biology of Blood and Marrow Transplantation
Journal Review
Journal of Interferon Research
Clinical Cancer Research
Bone Marrow Transplantation
Journal of Immunology
Experimental Hematology
Transplantation
Transfusion Medicine
Journal of Clinical Investigations
Cancer Immunology & Immunotherapy

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1986 - 1990 Member, Board of Trustees, Wisconsin Chapter of the Leukemia Society of America, Inc.
1991 - 1995 Member, Board of Trustees, Wisconsin Chapter of the Leukemia Society of America, Inc.
1999 - Present Member, Scientific Committee, Wisconsin Breast Cancer Showhouse for a Cure
2001 Member, Steering Committee, Great Lakes International Imaging and Flow Cytometry Association
03/2003 Member, Cancer Center Community Advisory Board, Medical College of Wisconsin

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1978 Site Visitor, Division of Cancer Research Resources and Centers, NCI
1983 Special Reviewer, Experimental Immunology Study Section, NIH
1984 - 1990 Member, Nominating Committee, International Association for Gnotobiotics
1987 Member, Experimental Immunology Ad Hoc Study Sections, NIH
1987 Site Visitor, Program Project Grant Reviews, NCI
1988 Site Visitor, Program Project Grant Reviews, NCI
1988 Member, Bone Marrow Transplant Ideas and Planning Committee, Pediatric Oncology Group
1988 Chair, Program Project Grant Reviews, NCI
1989 Chair, Program Project Grant Reviews, NCI
1990 Member, Experimental Immunology Ad Hoc Study Sections, NIH
1990 Consultant to Pediatric Branch, Neuroblastoma Immunotherapy Protocol, NCI
1991 Chair, Program Project Grant Reviews, NCI
1992 Chair, Program Project Grant Reviews, NCI
1992 Member, Experimental Immunology Ad Hoc Study Sections, NIH
1992 Ad Hoc Member, Subcommittee F - Cancer Research Manpower, NCI
1993 Site Visitor, Division of Cancer Research Resources and Centers, NCI
1993 - 1996 Full member, Subcommittee F - Cancer Research Manpower, NCI
1994 - 1996 Member, Tumor Immunology Scientific Subcommittee, American Society for Blood and Marrow Transplantation
1995 Chair, Program Project Grant Reviews, NCI
1996 Member, Ad Hoc Committee, T32 Application
1996 Chair, Program Project Grant Reviews, NCI
1996 - 1998 Ad Hoc Member, Subcommittee D - Clinical Program Projects Review Group, NCI
1996 Member, Ad Hoc Committee, Minority K08 Applications
1997 Chair, Program Project Grant Reviews, NCI
02/1998 Ad Hoc Member, Subcommittee F - Cancer Research Manpower, NCI
07/1998 - 06/1999 Special Reviewer, Experimental Therapeutics II (ET-2) IRG, NIH
1998 Chair, Program Project Grant Reviews, NCI
06/1999 Special Reviewer, Experimental Therapeutics II (ET-2) IRG, NIH
11/1999 Ad Hoc Reviewer, Subcommittee G - Education, NCI
1999 Chair, Program Project Grant Reviews, NCI
1999 Member, Subcommittee G - Education, NCI
1999 Teleconference Review, Subcommittee D - Clinical Program Projects Review Group, NCI
06/2000 Ad Hoc Member, Subcommittee F - Cancer Research Manpower, NCI
06/2000 Ad Hoc Reviewer, Subcommittee G - Education, NCI
2000 Chair, Program Project Grant Reviews, NCI
2000 Member, Subcommittee G - Education, NCI
2000 - 2007 Member, External Advisory Committee, University of Kentucky’s Program Project Grant on “Growth, Regulation and Therapy of Leukemia and Lymphoma”
2001 Chair, Program Project Grant Reviews, NCI
2001 Study Section Boundary Team, Center for Scientific Review’s Oncological Sciences, NIH
2001 Intramural Review, Experimental Immunology Branch, National Cancer Institute, NIH
06/2002 Ad Hoc Member, Subcommittee F - Cancer Research Manpower, NCI
11/2002 Ad Hoc Member, Subcommittee F - Cancer Research Manpower, NCI
2002 Chair, Program Project Grant Reviews, NCI
2002 External Scientific Advisor, External Review Panel, IBMTR/ABMTR
2002 Ad Hoc Member, Subcommittee D - Clinical Program Projects Review Group, NCI
2003 Reviewer, Loan Repayment Program, NIH
2003 Special Emphasis Panel, Experimental Therapeutics-II Study Section, NIH
2003 Ad hoc, Project Grant Review, NHLBI Program
2004 - 2007 Member, Elected to Board of Directors, American Society for Blood and Marrow Transplantation
2004 Ad hoc, Project Grant Review, NHLBI Program
2004 Reviewer, Loan Repayment Program, NIH
2004 Intramural Review, Experimental Transplantation and Immunology Branch, NIH
2004 - 2007 Member, Membership Committee, American Society for Blood and Marrow Transplantation
2005 Reviewer, Loan Repayment Program, NIH
2005 Member, Project Grants on Hematopoietic Stem Cell Transplantation, NCI Cluster Reviews for Program
2005 Member, Scientific Peer Review Committee (Immunotherapy), DOD Breast Cancer Research Program
2005 - 2006 Ad Hoc Member, Subcommittee D - Clinical Program Projects Review Group, NCI
2005 Member, NCRR Special Emphasis Panel, Centers of Biomedical Research Excellence
2006 - 2007 Chairperson, Membership Committee, American Society for Blood and Marrow Transplantation
2006 Discussion Leader and Reviewer, Special Emphasis Panel, NCI Clinical Sciences
2006 Member, Project Grants on Hematopoietic Stem Cell Transplantation, NCI Cluster Reviews for Program
2006 Ad hoc member, Study Section, NIH Center for Scientific Review “Transplatation, Tolerance and Tumor Biology”
2007 Founding Chairperson, Distance Learning Committee, American Society for Blood and Marrow Transplantation
2007 Reviewer, Loan Repayment Program, NIH
2007 Reviewer, NCI Special Emphasis Panel, Program Project Grant from FHCRC
2007 Member, NHLBI Program Project Special Review Committee, Dana-Farber Cancer Institute
2007 Ad hoc member, Study Section, NIH Center for Scientific Review “Transplatation, Tolerance and Tumor Biology”
2007 - Present Member, Distance Learning Committee, American Society for Blood and Marrow Transplantation
05/2008 - 10/2008 Reviewer, Oncology Fellowship (F09) Program, NIH Center for Scientific Review
2008 Reviewer, NCI Special Emphasis Panel, Program Project Grant from FHCRC
2008 Member, 1 Peer Review Committee, CDMRP Breast Cancer Research Program – Idea
2008 Ad Hoc Member, Subcommittee D - Clinical Program Projects Review Group, NCI
2008 Reviewer, Loan Repayment Program, NIH
2008 Ad hoc, Project Grant Review, NHLBI Program
2008 Member, NHLBI Program Project Special Review Committee, Dana-Farber Cancer Institute
06/2009 Reviewer, Oncology Fellowship (F09) Program, NIH Center for Scientific Review
2009 Teleconference Review, Subcommittee D - Clinical Program Projects Review Group, NCI
2009 Ad hoc, Project Grant Review, NHLBI Program
2009 Reviewer, Loan Repayment Program, NIH
02/2010 Reviewer, Oncology Fellowship (F09) Program, NIH Center for Scientific Review
10/2010 Reviewer, Oncology Fellowship (F09) Program, NIH Center for Scientific Review
2010 Member, Peer Review Committee, CDMRP Breast Cancer Research Program

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Immunology Research
Source:
Midwest Athletes Against Childhood Cancer (MACC) Fund
Dates:
1984 - Present
Direct Funds:
$10,000
  
Prior
Peer Review
Title:
Adoptive Immunotherapy in Decontaminated AKR Mice
Source:
NCI Grant R01 CA018440
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1975 - 1977
Direct Funds:
$210,256
  
Title:
Adoptive Immunotherapy for Carcinoma of the Colon
Source:
American Cancer Society-Milwaukee Division
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1976 - 1977
Direct Funds:
$7,000
  
Title:
Specific Adoptive Immunotherapy of AKR Leukemia
Source:
NCI Grant R01 CA020484
Role & Effort:
Co-Investigator
Dates:
1976 - 1982
Direct Funds:
$780,810
  
Title:
Adoptive Immunotherapy Using Endotoxin Treated Donors
Source:
NCI Grant R01 CA021998
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1977 - 1979
Direct Funds:
$79,099
  
Title:
Germfree Techniques Applied to Adoptive Immunotherapy
Source:
NCI Grant R01 CA018440
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1977 - 1980
  
Title:
Mechanism of Successful Adoptive Immunotherapy
Source:
NCI Grant R01 CA026245
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1979 - 1982
Direct Funds:
$246,779
  
Title:
All immunization for Induction of Antitumor Immunity
Source:
NCI Grant R01 CA028738
Role & Effort:
Co-Investigator
Dates:
1981 - 1982
Direct Funds:
$295,398
  
Title:
Injection Chimeras: An Innovative Approach to Adoptive Immunotherapy of Leukemia
Source:
Midwest Athletes Against Childhood Cancer Fund
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1981 - 1983
Direct Funds:
$20,000
  
Title:
Specific Adoptive Immunotherapy of AKR Leukemia
Source:
NCI Grant R01 CA020484
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1982 - 1985
Direct Funds:
$780,810
  
Title:
All immunization for Induction of Antitumor Immunity
Source:
NCI Grant R01 CA028738
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1982 - 1984
Direct Funds:
$295,398
  
Title:
Immunoregulatory T Cells in Transplantation Tolerance
Source:
NIAID Grant R01 AI022312 (3 years)
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1984 - 1988
Direct Funds:
$391,326
  
Title:
Transfer of CA028738 to MCW for years –01 through –02
Source:
NCI Grant R01 CA039854
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1984 - 1986
  
Title:
Adoptive Immunotherapy of Leukemia
Source:
Cancer Center of the Medical College of Wisconsin
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1985 - 1986
Direct Funds:
$5,000
  
Title:
Cytotoxic T-Cell Response to Minor Histocompatibility Antigens
Source:
Children's Hospital of Wisconsin Grant 84/25M
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1985 - 1987
Direct Funds:
$5,000
  
Title:
Clonal GVL/GVH Reactions and Adoptive Immunotherapy
Source:
NCI Grant R01 CA039854
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1986 - 1991
Direct Funds:
$694,000 (Competitive Renewal for years –03 through –07 40% effort)
  
Title:
Molecular detection of leukemia after allogeneic BMT
Source:
NCI K08 CA01534
Dates:
1991 - 1996
  
Title:
Institutional Research Grant
Source:
American Cancer Society
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1991 - 2010
Direct Funds:
$420,000 (for 3 years to support MCW Cancer Center's Research Grant Committee )
  
Title:
Effects of GVHD and Cyclosporin A on the Exocrine Pancreas
Source:
Cancer Center, MCW
Role & Effort:
Co-Investigator
PI:
Steve Werlin, M.D.
Dates:
1992
Direct Funds:
$9,991 (5% Effort)
  
Title:
Phase I/II Clinical Evaluation of Biological Response Modifiers for the Treatment of Cancer
Source:
NCI Master Agreement Order
Role & Effort:
Co-Investigator
PI:
Ernest C. Borden, M.D.
Dates:
1992 - 1994
Direct Funds:
$390,000 (5% Effort)
  
Title:
Manipulation of GVL/GVH Reactions in Allogeneic BMT
Source:
NCI Grant R01 CA039854
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1992 - 1996
Direct Funds:
$387,985 (Competitive Renewal for years –08 through –10 40% Effort)
  
Title:
Immune Receptor Targeted Therapy
Source:
Cancer Center, Medical College of Wisconsin
Role & Effort:
Co-Investigator
PI:
Joseph Barbieri, Ph.D.
Dates:
1993 - 08/1993
Direct Funds:
$10,000 (5% Effort)
  
Title:
Immune Receptor Targeted Therapy: IL12;Gelonin
Source:
Falk Foundation Cancer Research Merit Award, Cancer Center, MCW
Role & Effort:
Co-Investigator
PI:
Joseph Barbieri, Ph.D
Dates:
1994
Direct Funds:
$20,000 (5% Effort)
  
Title:
Synthesis and preclinical evaluation of antibody-dye conjugates for the prophylaxis of GVHD
Source:
Cancer Center, Medical College of Wisconsin
Role & Effort:
Co-Investigator
PI:
Fritz Sieber
Dates:
1994
Direct Funds:
$10,000 (5% Effort)
  
Title:
Role of gamma/delta T cells in all engraftment and GVHD
Source:
NHLBI Grant R29-HL055388
Role & Effort:
Co-Investigator
PI:
William R. Drobyski, MD
Dates:
1996 - 2002
  
Title:
Role of GM1-binding in the immunomodulatory effects of heat-labile E. coli enterotoxin subunit B (LTB)
Source:
Cancer Center, Medical College of Wisconsin
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1996
Direct Funds:
$10,000 (10% Effort)
  
Title:
PUVA Therapy to Prevent GVHD
Source:
Cerus Corporation
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1997 - 1998
Direct Funds:
$47,000 (10% Effort)
  
Title:
rLTB: A Novel Immunomodulatory Agent for Use in BMT
Source:
NCI Grant R01 CA073738
Role & Effort:
Principal Investigator
PI:
Self
Dates:
1997 - 2003
Direct Funds:
$420,355 (40% Effort)
  
Title:
Molecular staging and screening of lung cancer
Source:
NCI K08-CA76452
Dates:
1998 - 2001
  
Title:
Molecular and cellular analysis of T-cells during DLI
Source:
NCI K08-CA77330
Dates:
1998 - 2003
  
Title:
FACS Vantage SE
Source:
NCRR Grant S10 RR013784
Role & Effort:
Principal Investigator
PI:
Self
Dates:
2000 - 2001
Direct Funds:
$226,791 (0% Effort)
  
Title:
Characterization of Gut Mucosal T-cells in Children with Crohn’s Disease
Source:
NIH K23 Award
Dates:
2001 - 2005
  
Title:
Allospecific Immunoregulatory T Cells in BMT Recipients
Source:
NHLBI Grant R21 HL069721
Role & Effort:
Principal Investigator
PI:
Self
Dates:
2001 - 2005
Direct Funds:
$450,000 (30% Effort)
  
Title:
Regulatory T Cells Suppress Alloreactivity after BMT
Source:
NCI R01 CA090286
Role & Effort:
Co-Investigator
PI:
Bryon D. Johnson, PhD
Dates:
2001 - 2006
  
Title:
Collaborative Center for Multiple Sclerosis Research
Source:
John and Elizabeth Boynton Fund, Greater Milwaukee Foundation
Role & Effort:
Principal Investigator
PI:
Self
Dates:
2003 - 2006
Direct Funds:
$35,000
  
Title:
Role of CD200/CD200R interactions in tolerance to model autoantigen of systemic lupus erythematosus
Source:
Medical College of Wisconsin Research Affairs Committee
Role & Effort:
Principal Investigator
PI:
Self
Dates:
2004 - 2006
Direct Funds:
$15,000
  
Title:
Optimizing Immunotherapy for Neuroblastoma after BMT
Source:
NCI R01 CA100030
Role & Effort:
Co-Investigator
PI:
Bryon D. Johnson, PhD
Dates:
2004 - 2009
  
Title:
CD200 Expression on Apoptotic DCs and Immune Tolerance
Source:
NHLBI Grant R21 HL079792
Role & Effort:
Principal Investigator
PI:
Self
Dates:
2004 - 2007
Direct Funds:
$450,000 (25% Effort)
  
Title:
Center for Medical Countermeasures against Radiological Terrorism
Source:
2005-2010 NIAID 5U19AI067734
Role & Effort:
Chair, Pilot Grants Program
Dates:
2005 - 2010
Direct Funds:
$18,000,000 (5.8% effort)
  
Title:
Biophotonic Imaging Core
Source:
Advancing a Healthier Wisconsin Program Grant
Role & Effort:
Principal Investigator
PI:
Self
Dates:
2006
Direct Funds:
$150,000
  
Title:
CD200 on Mesenchymal Stem Cells and Immune Tolerance
Source:
Aylen Foundation
Role & Effort:
Co-Principal Investigator
Dates:
2007 - 2009
Direct Funds:
$55,000 (for two years )
  
Title:
Translational Studies of Tumor Cell-Based Vaccines
Source:
Midwest Athletes Against Childhood Cancer (MACC) Fund
Role & Effort:
Co-Principal Investigator
Dates:
2007 - 2010
Direct Funds:
$1,000,000 (over 3 years)
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
International
Japanese Society of Bone Marrow Transplantation, Fourteenth Annual Meeting, Sapporo, Japan, 12/1991
Initiation and Maintenance of Tumor Dormancy, Workshop on Cellular Immune Mechanisms, Ottawa, Ontario, 1991
Workshop Presentation, American Association for Cancer Research, Toronto, Canada, 1995
Memorial University, St. Johns, Newfoundland, Canada, 1996
Regulatory/Suppressive T Cells, Keystone Conference, Banff, Alberta, Canada, 2004
 
National
Scientific Program Advisory Committee, XIVth International Symposium for Comparative Research on Leukemia and Related Diseases, Vail, CO, 10/08/1989 - 10/12/1989
Use of Interleukin-2 in Hematologic Malignancies, NCI-INSERM Workshop, Bethesda, MD, 1991
Emory University, Atlanta, GA, 1992
Society for Biological Therapy, 8th Annual Meeting, Nashville, TN, 1993
Cellular Immunity and the Immunotherapy of Cancer, Taos, NM, 1993
BMT: Basic and Clinical Research Studies, National Heart, Lung, and Blood Institute, Workshop on GVH Disease and Other Immunologic Complications of Unrelated-Donor, Bethesda, MD, 03/10/1994 - 03/11/1994
American Society for Histocompatibility and Immunogenetics, Pittsburgh, PA, 10/1994
American Society of Hematology, Nashville, TN, 12/1994
BMT Program, National Heart, Lung and Blood Institute, Bethesda, MD, 1994
Advances and Controversies in Bone Marrow Transplantation, Keystone, CO, 1994
American Society of Blood and Marrow Transplantation, Keystone, CO, 01/1995
Workshop Presentation, American Society for Histocompatibility and Immunogenetics, Dallas, TX, 10/1995
Blood Cell and Bone Marrow Transplants, Keystone Symposium, Keystone, CO, 01/15/1996 - 01/21/1996
American Society for Blood and Marrow Transplantation, San Diego, CA, 1996
Department of Microbiology and Immunology, University of North Dakota, Grand Forks, ND, 1996
American Society for Histocompatibility and Immunogenetics, Regional Meeting, Hilton Head, SC, 03/1997
Transplantation Society, Fifth Basic Sciences Symposium, Chautauqua, NY, 1997
American Society for Hematology, Miami Beach, FL, 1998
Preclinical Models of GVL Reactivity, American Society for Blood and Marrow Transplantation, Anaheim, CA, 03/29/2000 - 04/01/2000
Animal Models in GVL, American Society for Blood and Marrow Transplantation, Anaheim, CA, 03/2000
Oral Session Co-chair: Experimental BMT: Novel Approaches to Optimize GVL/GVT Responses, American Society of Hematology, San Francisco, CA, 12/2000
American Society for Hematology, Annual Meeting, San Francisco, CA, 12/2000
Cellular Immunity and Immunotherapy of Cancer, Keystone Symposium, Santa Fe, NM, 2000
Women for MACC, 11/2003
Immune Tolerance, Keystone Symposium, Snowbird, UT, 2003
ASBMT/IBMTR, Tandem Meeting, Keystone, CO, 2003
Mortimer M. Bortin Lecture, Tandem BMT Meeting, Orlando, FL, 02/2004
University of Wisconsin Comprehensive Cancer Center, Oncology Grand Rounds, Madison, WI, 2005
University Club, 10/2006
Opportunities for PhDs in Hematology Research, American Society for Hematology Annual Meeting, San Francisco, CA, 2008
Mechanisms of Funding for PhDs, Trainee Day, American Society for Hematology Annual Meeting, New Orleans, LA, 2009
 
Regional
Gnotobiology, VIII International Symposium, University of Notre Dame, Notre Dame, IN, 06/18/1984 - 06/22/1984
IBMTR Participating Teams, First Annual Meeting, Providence, RI, 07/1992
Bone Marrow Transplantation, Keystone, CO, 1992
22nd Annual, Autumn Immunology Conference, Chicago, IL, 1993
American Society of Pediatric Hematology/Oncology, Chicago, IL, 10/1994
Cancer Center, University of Minnesota Medical School, Minneapolis, MN, 1995
Bone Marrow Transplantation Program, Northwestern University, Evanston, IL, 1996
Midwest Division of the American Cancer Society, Dubuque, IA, 10/1999
American Society for Blood and Marrow Transplantation, Keystone, CO, 1999
Great Lakes International Imaging and Flow Cytometry Association, 10th Annual Meeting, 10/12/2001 - 10/14/2001
 
Local
Alien Histocompatibility Antigens on Cancer Cells, First International Symposium, Wingspread Conference Center, Racine, WI, 05/20/1979 - 05/22/1979
Alien Histocompatibility Antigens in Cancer, Second International Symposium, Wingspread Conference Center, Racine, WI, 10/08/1980 - 10/11/1980
Cellular Immunotherapy of Cancer, International Symposium, Wingspread Conference Center, Racine, WI, 10/30/1986 - 11/01/1986
Co-organizer, Workshop on Use of Flow Cytometry in Clinical Medicine, Medical College of Wisconsin, Milwaukee, WI , WI, 11/08/1986
Scientific Program Committee, Sixth Annual Marquette Life Sciences Symposium, Milwaukee, WI, 03/17/1989 - 03/18/1989
Frontiers in Cancer Biology, Scientific Program Committee, MCW Cancer Center, 04/06/1991
Association for Gnotobiotics, Madison, WI, 1992
Association for Gnotobiotics, 30th Annual Meeting, Madison, WI, 1992
Wisconsin-American Cancer Society, Annual Dinner, 04/2000
Waukesha Rotary Club, 05/2003
Cancer Media Day, Medical College of Wisconsin, Milwaukee, WI, 11/2003
American Cancer Society, Donor Recognition Dinner, 05/2004
Crystal Ball, American Cancer Society, 05/2007
First MACC Fund, Scientific Symposium, Milwaukee, WI, 06/19/2007
Second MACC Fund, Scientific Symposium, Madison, WI, 12/16/2009
 

COMMITTEE SERVICE:
Medical College of Wisconsin
1985 - 1990 Member, Cancer Center Executive Committee, Medical College of Wisconsin
1987 - 1994 Member, Flow Cytometry Oversight Committee, Cancer Center, Medical College of Wisconsin
1988 - Present Member, Promotions Committee, Department of Pediatrics, Medical College of Wisconsin
1990 - Present Chairman, Research Grants Committee, Cancer Center, Medical College of Wisconsin
1990 - 1992 Elected, Cancer Center Executive Committee, Medical College of Wisconsin
1991 Chairman, Flow Cytometry Oversight Committee, Cancer Center, Medical College of Wisconsin
1992 - 1994 Member, Cancer Education Committee, Cancer Center, Medical College of Wisconsin
1993 - 1994 Member, Cancer Center Executive Committee, Medical College of Wisconsin
1994 - 1995 Chairperson, Taskforce on Responsible Conduct of Research, Department of Pediatrics, Medical College of Wisconsin
1994 Member, Planning Committee, Cancer Center, Medical College of Wisconsin
1994 - 2000 Member, Research Committee, Department of Pediatrics, Medical College of Wisconsin
1994 - 2000 Member, Research Strategic Advisory Committee, Cancer Center Research Advisory Group, Medical College of Wisconsin
1995 - 2000 Member, Shared Facilities Oversight Committee, Medical College of Wisconsin
1997 Member, 25th Anniversary Celebration Committee, IBMTR
1998 Planning Director, Planning Committee, Cancer Center, Medical College of Wisconsin
1999 - 2000 Member, Director Search Committee, Cancer Center, Medical College of Wisconsin
1999 - 2000 Member, Onc Chief Search Committee, Division of Hem, Department of Medicine, Medical College of Wisconsin
1999 Member, Chief Search Committee, Division of Urology, Department of Surgery, Medical College of Wisconsin
1999 - 2000 Vice Chair, Basic Research, Department of Pediatrics, Medical College of Wisconsin
2000 - Present Chair, Oversight Committee, Flow Cytometry Core Facility, Medical College of Wisconsin
2001 - 2004 Chair, Search Committee, Department of Biochemistry, Medical College of Wisconsin
2002 - 2004 Chair, Core Facilities Committee, Medical College of Wisconsin
2003 - 2004 Member, Planning Task Force, Cancer Center, Medical College of Wisconsin
2003 Member, Scientific Protocol Review Committee, Cancer Center, Medical College of Wisconsin
2004 - 2005 Member, Search Committee for Associate Director, Human Molecule Genetics Center, Medical College of Wisconsin
2005 Member, Basic Science Research Task Force, Children’s Research Institute, Department of Pediatrics, Medical College of Wisconsin
2005 - Present Member, Search Committee for Cancer Center Director, Cancer Center, Medical College of Wisconsin
2007 Member, Advancing a Healthier Wisconsin Focus Group, Medical College of Wisconsin
2007 - Present Member, Search Committee for Chair of Dermatology, Medical College of Wisconsin
2007 - Present Member, Core Facilities Committee, Medical College of Wisconsin
2007 - Present Chair, Biophotonic Imaging Core Oversight Committee, Medical College of Wisconsin
2009 Member, Search Committee, Chief of Surgical Oncology, Medical College of Wisconsin
2009 - Present Member, Steering Committee, Biospecimen Resource Center, Medical College of Wisconsin
 
Hospital
1985 - 2006 Member, Institutional Review Board/Human Rights Review Committee, Children's Hospital of Wisconsin
 

MCW TEACHING ACTIVITIES:
Medical Student Education
1986 - 1998 Preceptor for Summer Medical Students
1987 - 2009 Lectures on cellular immunology and transplantation immunology, Medical Microbiology course, Department of Microbiology
12/16/1994 Pediatric Grand Rounds, "Graft-vs-Leukemia Effects"
1995 Cellular and Molecular Immunology, Micro 234: Lectures on Transplantation Immunology
1995 Midwest Children's Cancer Center Research Presentations
1996 Midwest Children's Cancer Center Research Presentations
1997 Cellular and Molecular Immunology, Micro 234: Lectures on Transplantation Immunology
1997 Grant Writing Seminar: “NIH Grants: a reviewer’s perspective”, Department of Pediatrics
04/1998 Allergy and Immunology Division Grant Rounds
1998 - 2000 Panel Participant-MCW graduate course on Ethics and Integrity in Science
1999 Cellular and Molecular Immunology, Micro 234: Lectures on Transplantation Immunology
1999 Interdisciplinary Graduate Program Faculty Lectures
10/2001 Clinical Research Scholars Program Lecture
2001 Cellular and Molecular Immunology, Micro 234: Lectures on Transplantation Immunology
2001 Preceptor for Summer Medical Students
04/2002 Allergy and Immunology Division Grant Rounds
07/2002 Pediatric Academic Conference
2004 Cellular and Molecular Immunology, Micro 234: Lectures on Transplantation Immunology
03/2005 Allergy and Immunology Grand Rounds
10/2005 Lecturer, Advanced Cell Biology Graduate Course on Stem Cell Biology
03/2006 Pediatric Grand Rounds, “Regulatory T Cells: The New Immunosuppression”
2007 - 2009 Panel Participant-MCW graduate course on Ethics and Integrity in Science
2007 Cellular and Molecular Immunology, Micro 234: Lectures on Transplantation Immunology
11/2008 - 01/2008 Lecture on “Bioluminescent/Fluorescent Imaging” for Pharmacology 07243: Analytical Methods in Pharmacology and Toxicology
2009 Cellular and Molecular Immunology, Micro 234: Lectures on Transplantation Immunology
08/2010 Lecture on “Bioluminescent/Fluorescent Imaging” for Pharmacology 07243: Analytical Methods in Pharmacology and Toxicology
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Undergraduate Students
1994 Malaka Jackson, Minority Student Research Program, Medical College of Wisconsin
1995 Crystal Ruffin, Minority Student Research Program, Medical College of Wisconsin
1997 Chenoa Parsons, Minority Student Research Program, Medical College of Wisconsin
1999 Elizabeth Hernandez, Minority Student Research Program, Medical College of Wisconsin
 
Medical Students
1986 Prakash Shah, Ph.D., Medical College of Wisconsin
1987 Jan Jeske, Medical College of Wisconsin
1991 - 1993 Michael Weiler, Medical College of Wisconsin
1993 - 1994 Cathleen McCabe, Recipient of 1996 Armand J. Quick Award for Outstanding Senior Medical Student in Biochemistry, Medical College of Wisconsin
2001 Paul Jeppsen, Medical College of Wisconsin
 
Graduate Students
MS Committees
1987 - 1992 Jeanette Bjerke, Department of Microbiology, Medical College of Wisconsin
1993 - 1997 Geri Lyons, Department of Microbiology & Molecular Genetics, Medical College of Wisconsin
1993 - 1995 Jon D'Cunha, Department of Microbiology & Molecular Genetics, Medical College of Wisconsin
2002 Lianne Marks, Department of Microbiology & Molecular Genetics, Medical College of Wisconsin
2005 - 2009 Lance Relland, Department of Microbiology & Molecular Genetics, Medical College of Wisconsin
2005 - 2009 Eric Kohler, Department of Microbiology & Molecular Genetics, Medical College of Wisconsin
PhD Students Advised
1997 - 2001 James LaBelle, MD, PhD, Medical College of Wisconsin
MS Students Advised
1998 Michael Rosenblum, Medical College of Wisconsin
1999 Kelli Rose, Interdisciplinary Graduate Program, Medical College of Wisconsin
PhD Committees
2000 - 2003 Michael Rosenblum, MD, PhD, Department of Microbiology & Molecular Genetics, Medical College of Wisconsin
 
Postdoctoral Researchers
1988 - 1990 William Drobyski, M.D., Professor, Department of Medicine, Medical College of Wisconsin
1989 - 1992 Bryon Johnson, Ph.D., Associate Professor, Department of Pediatrics, Medical College of Wisconsin
2001 - 2005 Jeffrey Woodliff, Ph.D., Assistant Professor, Department of Pediatrics, Medical College of Wisconsin
 
Faculty
10/1991 - 09/1996 William R. Drobyski, M.D., National Cancer Institute K08-CA01534, “Molecular detection of leukemia after allogeneic BMT”, Medical College of Wisconsin
03/1998 - 02/2001 Steven Ahrendt, M.D., National Cancer Institute K08-CA76452, “Molecular staging and screening of lung cancer”, Medical College of Wisconsin
12/1998 - 11/2003 David A. Margolis, M.D., National Cancer Institute K08-CA77330, “Molecular and cellular analysis of T-cells during DLI”, Medical College of Wisconsin
2001 - 2005 Subra Kuagthasan, M.D., NIH K23 Award, “Characterization of Gut Mucosal T-cells in Children with Crohn’s Disease”, Medical College of Wisconsin
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
High School Students
2003 - 2004 Benjamin Boxer, Participant in International Science and Engineering Fair
 
Medical Students
1988 - 1989 Ayse Atasoylu, Transitional Year Internship, Cambridge Health Alliance, Harvard Medical School
 
Graduate Students
PhD Students Advised
1981 - 1984 Chiu-Yang Shih, Ph.D., Marquette University
 
Postdoctoral Researchers
1981 - 1983 Ann V. LeFever, Ph.D., Present position - Director, Immunotherapy Program, St. Luke's Medical Center
1985 - 1986 Chiu-Yang Shih, Ph.D., Research Section Head, San Diego, CA, PharMingen
1994 - 1996 Nina A. Garlie, Ph.D., Immunotherapy Program, St. Luke's Medical Center
2003 - 2007 Michael Rosenblum, Ph.D., Dermatology Residency and Fellowship, University of California - San Francisco
2007 - 2009 Cheryl Cameron, M.D., Pediatric Hematology/Oncology/Transplant Fellow, Children’s Hospital of Wisconsin
 

AD HOC GRANT REVIEWS:
2003 Veteran's Administration; Netherlands Cancer Foundation (Stichting Koningin Wilhelmina Fonds); National Foundation - March of Dimes; United States-Israel Binational Science Foundation; North Carolina Board of Science and Technology; Kay Kendall Leukemia Fund, United Kingdom
2006 Veteran's Administration; Netherlands Cancer Foundation (Stichting Koningin Wilhelmina Fonds); National Foundation - March of Dimes; United States-Israel Binational Science Foundation; North Carolina Board of Science and Technology; Kay Kendall Leukemia Fund, United Kingdom
2008 Veteran's Administration; Netherlands Cancer Foundation (Stichting Koningin Wilhelmina Fonds); National Foundation - March of Dimes; United States-Israel Binational Science Foundation; North Carolina Board of Science and Technology; Kay Kendall Leukemia Fund, United Kingdom
2009 Veteran's Administration; Netherlands Cancer Foundation (Stichting Koningin Wilhelmina Fonds); National Foundation - March of Dimes; United States-Israel Binational Science Foundation; North Carolina Board of Science and Technology; Kay Kendall Leukemia Fund, United Kingdom

LISTED IN::
Who's Who in Science and Engineering, Who's Who in the Midwest, Who's Who in Medicine and Health Care, American Men and Women of Science, Who's Who in the World

PATENTS:
01/31/2005 US Patent Application # 20050169870 Methods of Modulating CD200 DNAX Research Institute, Palo Alto, CA (Role: Co-Inventor with M. Rosenblum and E. Olasz)

WORKSHOP REPORT:
1975 The germ-free state: Transplantation aspects. Transplantation Proceedings 7(S1): 907 909


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. McFadden GK, Truitt RL, Shechmeister IL. Ultrastructural examination of phytohemagglutinin stimulated lymphocytes infected with vesicular stomatitis virus. Arch Gesamte Virusforsch. 1973;41(3):229-37.
2. Truitt RL, Schechmeister IL. The replication of bovine viral diarrhea-mucosal disease virus in bovine leukocytes in vitro. Arch Gesamte Virusforsch. 1973;42(1):78-87.
3. Pollard M, Truitt RL. Allogeneic bone marrow chimerism in germfree mice. 1. Prevention of spontaneous leukemia in AKR mice. Proc Soc Exp Biol Med. 1973 Nov;144(2):659-65.
4. Pollard M, Truitt RL. Allogeneic bone marrow chimerism in germ-free mice. II. Prevention of reticulum cell sarcomas in SJL-J mice. Proc Soc Exp Biol Med. 1974 Feb;145(2):488-92.
5. Truitt RL, Pollard M, Srivastava KK. Allogeneic bone marrow chimerism in germfree mice. 3. Therapy of leukemic AKR mice. Proc Soc Exp Biol Med. 1974 May;146(1):153-8.
6. Rose WC, Rimm AA, Saltzstein EC, Truitt RL, Bortin MM. Low-dose chemotherapy as a prelude to intensive treatment of spontaneous leukemia-lymphoma in AKR mice. J Natl Cancer Inst. 1975 Jul;55(1):219-21.
7. Bortin MM, Rose WC, Truitt RL, Rimm AA, Saltzstein EC, Rodey GE. Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice. J Natl Cancer Inst. 1975 Nov;55(5):1227-9.
8. Truitt RL, Pollard M. Allogeneic bone marrow chimerism in germ-free mice. IV. Therapy of "Hodgkin's-like" reticulum cell sarcoma in SJL mice. Transplantation. 1976 Jan;21(1):12-6.
9. Rose WC, Rodey GE, Rimm AA, Truitt RL, Bortin MM. Mitigation of graft-versus-host disease in mice by treatment of donors with bacterial endotoxin. Exp Hematol. 1976 Mar;4(2):90-6.
10. Bortin MM, Rimm AA, Rose WC, Truitt RL, Saltzstein EC. Transplantation of hematopoietic and lymphoid cells in mice. Transplantation. 1976 Apr;21(4):331-6.
11. Pollard M, Truitt RL, Ashman RB. Mouse leukemia and solid tumors treated with bone marrow grafting. Transplant Proc. 1976 Dec;8(4):565-7.
12. Bortin MM, Truitt RL, Rose WC, Rimm AA, Saltzstein EC. Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR mice. Adv Exp Med Biol. 1976;73 Pt B:331-9.
13. Truitt RL, Rimm AA, Saltzstein EC, Rose WC, Bortin MM. Graft-versus-leukemia for AKR spontaneous leukemia-lymphoma. Transplant Proc. 1976 Dec;8(4):569-74.
14. Bortin-M, Truitt RL. AKR T-cell acute lymphoblastic leukemia: a model for human T-cell leukemia. Biomedicine. 1977 Oct;26(5):309-11.
15. Truitt RL, Rose WC, Rimm AA, Bortin MM. Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharide. Exp Hematol. 1978 May;6(5):488-98.
16. Saltzstein EC, Rose WC, Truitt RL, Rimm AA, Bortin MM, Patillo RA. Growth of human tumors in lethally irradiated mice reconstituted with syngeneic fetal liver cells. Cancer. 1977 Feb;39(2):581-6.
17. Bortin MM, Truitt RL, Rimm AA, Bach FH. Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity. Nature. 1979 Oct 11;281(5731):490-1.
18. Truitt RL, Bortin MM, Rimm AA. Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice. Transplant Proc. 1980 Mar;12(1):143-6.
19. Bortin MM, Truitt RL, Shih CY, Rimm AA. Graft-versus-leukemia: allosensitization of MHC compatible donors induces antileukemic reactivity without amplification of antihost reactivity. Haematol Blood Transfus. 1980;25:31-9.
20. Truitt RL, Shih CY, Rimm AA, Tempelis LD, Bortin MM. Alloimmunization and adoptive immunotherapy of leukemia. Transplant Proc. 1981 Dec;13(4):1910-4.
21. Shih CY, Truitt RL, Andreani M, Bortin MM. Growth of AKR T cell leukemia lymphoblasts in medium containing interleukin 2 (IL-2). In Vitro. 1983 Oct;19(10):759-66.
22. Bortin MM, Truitt RL, Shih CY, Tempelis LD, LeFever AV, Rimm AA. Alloimmunization for induction of graft-versus-leukemia reactivity in H-2-compatible donors: critical role for incompatibility of donor and alloimmunizing strains at non-H-2 loci. Transplant Proc. 1983 Dec;15(4):2114-7.
23. Truitt RL, Shih CY, Lefever AV, Tempelis LD, Andreani M, Bortin MM. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo. J Immunol. 1983 Oct;131(4):2050-8.
24. LeFever AV, Truitt RL, Shih CC, Liepins A, Bortin MM. Migration patterns and functional activity of cloned cytotoxic T lymphocytes in syngeneic and allogeneic mice. Transplantation. 1984 Apr;37(4):410-7.
25. Truitt RL, Shih CC. Isolation of suppressor-like T cells from bacteria-free allogeneic bone marrow chimeras. Prog Clin Biol Res. 1985;181:451-4.
26. LeFever AV, Truitt RL, Shih CC. Reactivity of in-vitro-expanded alloimmune cytotoxic T lymphocytes and Qa-1-specific cytotoxic T lymphocytes against AKR leukemia in vivo. Transplantation. 1985 Nov;40(5):531-7.
27. Truitt RL, Shih CC, LeFever AV. Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma. Transplantation. 1986 Mar;41(3):301-10.
28. LeFever AV, Truitt RL. Kinetic analysis of cloned cytotoxic T lymphocyte reactivity against normal and leukaemic target cells. J Immunogenet. 1986;13(2-3):275-85.
29. LeFever AV, Truitt RL. Kinetic analysis of Qa-1-specific cloned cytotoxic T lymphocytes: lytic parameters and evaluation of cellular inhibition. Scand J Immunol. 1987 Jun;25(6):541-53.
30. Shih CC, Truitt RL. A class II antigen-specific T cell clone can suppress graft-versus-host reactivity in murine allogeneic bone marrow chimeras. Transplant Proc. 1987 Feb;19(1 Pt 3):2664-7.
31. Shih CC, Truitt RL. Downregulation of L3T4+ cytotoxic T lymphocytes by interleukin-2. Science. 1987 Oct 16;238(4825):344-7.
32. Truitt RL, Ash RC. Manipulation of T-cell content in transplanted human bone marrow: effect on GVH and GVL reactions. Prog Clin Biol Res. 1987;244:409-21.
33. LeFever AV, Truitt RL. Migration of cytotoxic effector cells. Prog Clin Biol Res. 1987;244:313-24.
34. Shih CC, Truitt RL. Prophylaxis of graft-vs-host disease by adoptive transfer of a class II antigen-specific murine T-cell clone. Prog Clin Biol Res. 1987;244:439-47.
35. Bunin NJ, Casper JT, Chitambar C, Hunter J, Truitt R, Menitove J, Camitta BM, Ash R. Partially matched bone marrow transplantation in patients with myelodysplastic syndromes. J Clin Oncol. 1988 Dec;6(12):1851-5.
36. Liepins A, LeFever A, Truitt RL. Serotonin modulated Ca++ dependent K+ channels in alloimmune effector cell lytic function. Immunopharmacol Immunotoxicol. 1989;11(2-3):165-78.
37. Drobyski W, Thibodeau S, Truitt RL, Baxter-Lowe LA, Gorski J, Jenkins R, Gottschall J, Ash RC. Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism. Blood. 1989 Nov 01;74(6):2285-94.
38. Marmont AM, Gale RP, Butturini A, Goldman JM, Martelli MF, Prentice HG, Slavin S, Storb R, Truitt RL, Van Bekkum DW. T-cell depletion in allogeneic bone marrow transplantation: progress and problems. Haematologica. 1989;74(3):235-48.
39. LeFever A, Liepins A, Truitt R. Role of K+ ion channels in lymphokine-activated killer (LAK) cell lytic function. Immunopharmacol Immunotoxicol. 1989;11(4):571-82.
40. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringdén O, Rozman C, Speck B. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990 Feb 01;75(3):555-62.
41. Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med. 1990 Feb 22;322(8):485-94.
42. Drobyski WR, Piaskowski V, Ash RC, Casper JT, Truitt RL. Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow. Transplantation. 1990 Oct;50(4):625-32.
43. LeFever AV, Piaskowski VD, Casper JT, Truitt RL. Kinetic analysis of human IL-2 activated cytotoxic cells. Immunopharmacol Immunotoxicol. 1991;13(1-2):147-68.
44. Truitt RL, Atasoylu AA. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation. Blood. 1991 Jun 01;77(11):2515-23.
45. Truitt RL, Atasoylu AA. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow. Bone Marrow Transplant. 1991 Jul;8(1):51-8.
46. Drobyski WR, LeFever AV, Truitt RL. Regulation of lymphokine-activated killer activity in T-replete and T-cell-depleted human bone marrow by interleukin 4. Exp Hematol. 1991 Oct;19(9):950-7.
47. Johnson BD, Truitt RL. A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo. Transplantation. 1992 Jul;54(1):104-12.
48. Truitt RL, Piaskowski V, Kirchner P, McOlash L, Camitta BM, Casper JT. Immunological evaluation of pediatric cancer patients receiving recombinant interleukin-2 in a phase I trial. J Immunother (1991). 1992 May;11(4):274-85.
49. Drobyski WR, Baxter-Lowe LA, Truitt RL. Detection of residual leukemia by the polymerase chain reaction and sequence-specific oligonucleotide probe hybridization after allogeneic bone marrow transplantation for AKR leukemia: a murine model for minimal residual disease. Blood. 1993 Jan 15;81(2):551-9.
50. Johnson BD, Drobyski WR, Truitt RL. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant. 1993 Apr;11(4):329-36.
51. Johnson BD, Truitt RL. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease. Blood. 1995 Jun 01;85(11):3302-12.
52. Johnson BD, McCabe C, Hanke CA, Truitt RL. Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation. J Immunol. 1995 May 15;154(10):5542-54.
53. Flomenberg P, Piaskowski V, Truitt RL, Casper JT. Characterization of human proliferative T cell responses to adenovirus. J Infect Dis. 1995 May;171(5):1090-6.
54. Casper J, Camitta B, Truitt R, Baxter-Lowe LA, Bunin N, Lawton C, Murray K, Hunter J, Pietryga D, Garbrecht F. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood. 1995 May 01;85(9):2354-63.
55. Ritch PS, Keever C, Schiller J, Rivkin S, Witt PL, Grossberg SE, Truitt RL, Burris H, von Hoff DD, Vaickus L. Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy. Ann N Y Acad Sci. 1995 Jul 21;762:359-60.
56. D'Cunha J, Knight E Jr, Haas AL, Truitt RL, Borden EC. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A. 1996 Jan 09;93(1):211-5. PMCID: PMC40208
57. Keever-Taylor CA, Witt PL, Truitt RL, Ramanujam S, Borden EC, Ritch PS. Hematologic and immunologic evaluation of recombinant human interleukin-6 in patients with advanced malignant disease: evidence for monocyte activation. J Immunother Emphasis Tumor Immunol. 1996 May;19(3):231-43.
58. Margolis D, Camitta B, Pietryga D, Keever-Taylor C, Baxter-Lowe LA, Pierce K, Kupst MJ, French J 3rd, Truitt R, Lawton C, Murray K, Garbrecht F, Flomenberg N, Casper J. Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. Br J Haematol. 1996 Jul;94(1):65-72.
59. Johnson BD, Hanke CA, Truitt RL. The graft-versus-leukemia effect of post-transplant donor leukocyte infusion. Leuk Lymphoma. 1996 Sep;23(1-2):1-9.
60. Flomenberg P, Piaskowski V, Truitt RL, Casper JT. Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon. J Virol. 1996 Sep;70(9):6314-22. PMCID: PMC190657
61. Truitt RL, Hanke C, Radke J, Mueller R, Barbieri JT. Glycosphingolipids as novel targets for T-cell suppression by the B subunit of recombinant heat-labile enterotoxin. Infect Immun. 1998 Apr;66(4):1299-308. PMCID: PMC108053
62. Johnson BD, Hanke CA, Becker EE, Truitt RL. Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro. Cell Immunol. 1998 Nov 01;189(2):149-59.
63. Johnson BD, Becker EE, Truitt RL. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets. Biol Blood Marrow Transplant. 1999;5(3):123-32.
64. Truitt RL, Johnson BD, Hanke C, Talib S, Hearst JE. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation. J Immunol. 1999 Nov 01;163(9):5145-56.
65. Johnson BD, Becker EE, LaBelle JL, Truitt RL. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. J Immunol. 1999 Dec 15;163(12):6479-87.
66. Johnson BD, Dagher N, Stankowski WC, Hanke CA, Truitt RL. Donor natural killer (NK1.1+) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI. Biol Blood Marrow Transplant. 2001;7(11):589-95.
67. LaBelle JL, Hanke CA, Blazar BR, Truitt RL. Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia. Blood. 2002 Mar 15;99(6):2146-53.
68. LaBelle JL, Truitt RL. Characterization of a murine NKT cell tumor previously described as an acute myelogenous leukemia. Leuk Lymphoma. 2002 Aug;43(8):1637-44.
69. Johnson BD, Konkol MC, Truitt RL. CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Biol Blood Marrow Transplant. 2002;8(10):525-35.
70. Browning MB, Woodliff JE, Konkol MC, Pati NT, Ghosh S, Truitt RL, Johnson BD. The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells. Cell Immunol. 2004 Feb;227(2):129-39.
71. Rosenblum MD, Olasz E, Woodliff JE, Johnson BD, Konkol MC, Gerber KA, Orentas RJ, Sandford G, Truitt RL. CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance. Blood. 2004 Apr 01;103(7):2691-8.
72. Rosenblum MD, Olasz EB, Yancey KB, Woodliff JE, Lazarova Z, Gerber KA, Truitt RL. Expression of CD200 on epithelial cells of the murine hair follicle: a role in tissue-specific immune tolerance? J Invest Dermatol. 2004 Nov;123(5):880-7.
73. Xia G, Kovochich M, Truitt RL, Johnson BD. Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease. Biol Blood Marrow Transplant. 2004 Nov;10(11):748-60.
74. Rosenblum MD, Woodliff JE, Madsen NA, McOlash LJ, Keller MR, Truitt RL. Characterization of CD 200-receptor expression in the murine epidermis. J Invest Dermatol. 2005 Dec;125(6):1130-8.
75. Xia G, Truitt RL, Johnson BD. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras. Biol Blood Marrow Transplant. 2006 Apr;12(4):397-407.
76. Keever-Taylor CA, Browning MB, Johnson BD, Truitt RL, Bredeson CN, Behn B, Tsao A. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. Cytotherapy. 2007;9(2):144-57.
 
Books, Chapters, and Reviews
1. Bortin MM, Truitt RL, Rose WC, Rimm AA, Saltzstein EC. Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR mice. In: H Friedman, MR Escobar, and SM Reichard, eds. The Reticuloendothelial System in Health and Disease: Immunologic and pathologic aspects. Vol. 73B. New York: Plenum Press;1976:331-339.
2. LeFeber WP, Truitt RL, Rose WC, Bortin MM. Graft versus leukemia. VII. Donor selection for adoptive immunotherapy in mice. In: SJ Baum, GD Ledney eds. New York: Springer-Verlag;1977:239-246.
3. Truitt RL. Use of decontamination and a protected environment to prevent secondary disease following adoptive immunotherapy of acute leukemia in mice. In: SJ Baum, GD Ledney eds. Experimental Hematology Today. New York: Springer-Verlag;1978:195-201.
4. Bortin MM, Truitt RL, Rimm AA. Nonspecific adoptive immunotherapy of T cell acute leukemia in man. In: H Waters ed. The Handbook of Cancer Immunology: Immunotherapy. Vol.5. New York: Garland STPM Press;1978:403-429.
5. Truitt RL, Bortin MM, Rimm AA. Successful adoptive immunotherapy of AKR spontaneous T cell leukemia following antibiotic decontamination and protective isolation. In: T Fliedner, H Heit, D Niethammer, H Pfieger, eds. Clinical and Experimental Gnotobiotics. Stuttgart: Gustav Fischer Verlag;1979: 215-220.
6. Bortin MM, Truitt RL, Shih CC-Y, Rimm AA. Graft-versus-leukemia: Allosensitization of MHC compatible donors induces antileukemic reactivity without amplification of antihost reactivity. In: S Thierfelder, H Rodt, HJ Kolb, eds. Immunobiology of Bone Marrow Transplantation. New York: Springer-Verlag;1980:31-39.
7. MM Bortin, RT Truitt, ed. Alien histocompatibility antigens in cancer. New York: Grune and Stratton;1980.
8. RL Truitt, RP Gale, MM Bortin, eds. Cellular Immunotherapy of Cancer. New York: Alan R. Liss;1987.
9. Truitt RL, Johnson BD. Principles of graft-vs.-leukemia reactivity. Biol Blood Marrow Transplant. 1995 Dec;1(2):61-8.
10. Bortin MM, Truitt RL, Shih CC-Y, Rimm AA. Graft versus leukemia. X. Induction of reactivity against murine leukemia in MHC compatible donors. In: JP OKunewick, RF Meredith, eds. Graft-vs-Leukemia in Man and Animal Models. Boca Raton, FL: CRC Press;1981:139-156.
11. Fefer A, Truitt RL, Sullivan KM. Adoptive Cellular Therapy: Graft-vs-Tumor Responses after Bone Marrow Transplantation. In: VT DeVita, S Hellman and SA Rosenberg, eds. Biologic Therapy of Cancer: Principles and Practice. Philadelphia, PA: J.B. Lippincott Co.; 1991:237-246.
12. Horowitz MM, Truitt RL. Graft-versus-leukemia effects of bone marrow transplantation. In: K Atkinson, ed. Clinical Bone Marrow Transplantation. Cambridge UK: Cambridge University Press;1994:704-14.
13. Truitt RL, Johnson BD. Graft-versus-host disease and the graft-versus-leukemia effect: lessons from allogeneic bone marrow transplantation. In: T Spitzer, A Mazumder, eds. Immunotherapy and Bone Marrow Transplantation. Armonk, NY: Futura Publishing, Co.;1995:1-33.
14. Truitt RL, Keever C, Borden EC. Role of IL-4, IL-6, and IL-12 in cancer therapy. In: VT DeVita, S Hellman, SA Rosenberg, eds. Biologic Therapy of Cancer, Second Edition. Philadelphia: JB Lippincott Co.;1995:279-293.
15. Horowitz MM, Truitt RL. Graft-versus-leukemia effects of bone marrow transplantation. In: K Atkinson, ed. Clinical Bone Marrow and Blood Stem Cell Transplantation, Second Edition. Cambridge UK: Cambridge University Press;1999:1327-1338.
16. Truitt RL, Komgold R, Johnson BD, Townsend R, Blazar BR. Experimental animal models in the study of GVL reactions. In: J Barrett, Y-Z Jiang, eds. Allogeneic Immunotherapy for Malignant Diseases. New York: Marcel Dekker;2000:39-74.
17. Bredeson C, Horowitz MM, Truitt RL. Graft-versus-leukemia effects of bone marrow transplantation. In: K Atkinson, R Chaplin, J ritz, WE Fibbe, P Lungman, MK Brenner, eds. Clinical Bone Marrow Transplantation, Third Edition. Cambridge UK: Cambridge University Press;2004:291-310.
18. Bortin MM, Truitt RT, eds. Alien histocompatibility antigens in cancer, Volume II. New York: Grune and Stratton;1982.
19. Truitt RL. The Mortimer M. Bortin Lecture: to destroy by the reaction of immunity: the search for separation of graft-versus-leukemia and graft-versus-host. Biol Blood Marrow Transplant. 2004 Aug;10(8):505-23.
20. Rosenblum MD, Yancey KB, Olasz EB, Truitt RL. CD200, a "no danger" signal for hair follicles. J Dermatol Sci. 2006 Mar;41(3):165-74.
 
Abstracts
1. Pollard M, Truitt RL. Applications of germfree technology to experimental problems of clinical significance. Proc First Intersect Cong Int Assoc Microbiol Sci. 1975; 3:250-259.